ONDEXXYA
Live / Registered — Registered (as of 21 Jan 2020)
What this means for you
Registered since 21 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87621541
- Registration number
- 5967915
- Mark type
- Stylized text
- Filed
- 25 Sept 2017
- Published for opposition
- 06 Feb 2018
- Registered
- 21 Jan 2020
- Attorney of record
- Tara Rahemba
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation
Owner
- PORTOLA PHARMACEUTICALS, LLC, SOUTH SAN FRANCISCO, MO, US
- Portola Pharmaceuticals, Inc., South San Francisco, CA, US
- Portola Pharmaceuticals, Inc., South San Francisco, CA, US
- Portola Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 21 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Oct 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Feb 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Feb 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Nov 2019 — USE AMENDMENT FILED
- 16 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Nov 2019 — TEAS STATEMENT OF USE RECEIVED
- 03 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED